Skip to main content
Premium Trial:

Request an Annual Quote

Biocept Blood-Based Test for Prostate Cancer and Breast Cancer

Biocept has launched a CLIA-validated androgen receptor expression assay that uses a patient's blood to detect and monitor late-stage prostate cancer and a certain form of breast cancer. The assay uses circulating tumor cells from a simple blood draw to detect androgen receptor expression, which is prevalent in patients with advanced prostate cancer. The androgen receptor is also found in a subset of patients with estrogen receptor-negative, progesterone receptor-negative and Her2-negative breast cancer, known as triple negative breast cancer. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.